Harish Verma
Overview
Explore the profile of Harish Verma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohanty M, Govindaraj G, Ahmad M, Varose S, Tatkare M, Shete A, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066397
In order to maintain the polio eradication status, it has become evident that the surveillance of cases with acute flaccid paralysis and of environmental samples must be urgently supplemented with...
2.
Lopez Cavestany R, Eisenhawer M, Diop O, Verma H, Quddus A, Mach O
Pathogens
. 2024 Apr;
13(4).
PMID: 38668278
As the Global Polio Eradication Initiative (GPEI) strategizes towards the final steps of eradication, routine immunization schedules evolve, and high-quality vaccination campaigns and surveillance systems remain essential. New tools are...
3.
Sutter R, Eisenhawer M, Molodecky N, Verma H, Okayasu H
Pathogens
. 2024 Mar;
13(3).
PMID: 38535567
Inactivated poliovirus vaccine (IPV), available since 1955, became the first vaccine to be used to protect against poliomyelitis. While the immunogenicity of IPV to prevent paralytic poliomyelitis continues to be...
4.
Sharma A, Verma H, Estivariz C, Bajracharaya L, Rai G, Shah G, et al.
Lancet Microbe
. 2023 Sep;
4(11):e923-e930.
PMID: 37774729
Background: The polio eradication endgame required the withdrawal of Sabin type 2 from the oral poliovirus vaccine and introduction of one or more dose of inactivated poliovirus vaccine (IPV) into...
5.
Mohanty M, Desai M, Mohammad A, Aggarwal A, Govindaraj G, Bhattad S, et al.
Vaccines (Basel)
. 2023 Jul;
11(7).
PMID: 37515027
The emergence of vaccine-derived polioviruses (VDPVs) in patients with Primary Immunodeficiency (PID) is a threat to the polio-eradication program. In a first of its kind pilot study for successful screening...
6.
Mohanty M, Mohammad A, Verma H, Kumar A, Madkaikar M, Desai M, et al.
Bull World Health Organ
. 2023 May;
101(5):346-354.
PMID: 37131936
Individuals with primary immunodeficiencies who are infected with vaccine-derived polioviruses may continue to shed poliovirus for months and go undetected by surveillance programmes of acute flaccid paralysis. These patients therefore...
7.
Claire Endegue M, Sein C, Lopez Cavestany R, Jeyaseelan V, Palmer T, Norbert Soke G, et al.
Vaccine X
. 2022 Dec;
12:100244.
PMID: 36560978
Background: This study assessed seroprevalence of poliovirus antibodies in children from selected poliovirus high-risk areas of the Far North region of Cameroon which serves to monitor polio immunization program. Methods:...
8.
Aziz A, Verma H, Jeyaseelan V, Yunus M, Nowrin S, Moore D, et al.
J Infect Dis
. 2022 May;
226(8):1319-1326.
PMID: 35575051
Background: The polio eradication endgame called for the removal of trivalent oral poliovirus vaccine (OPV) and introduction of bivalent (types 1 and 3) OPV and inactivated poliovirus vaccine (IPV). However,...
9.
Verma H, Arun P, Sharan R, Manikantan K, Jain P
Indian J Surg Oncol
. 2022 Apr;
13(1):7-10.
PMID: 35462672
Hypocalcemia is the most common complication after total thyroidectomy. The aim of this study was to determine the predictors of postoperative hypocalcemia requiring augmentation of routine calcium supplementation. Prospectively collected...
10.
Bashorun A, Badjie Hydara M, Adigweme I, Umesi A, Danso B, Johnson N, et al.
Lancet Glob Health
. 2021 Dec;
10(2):e257-e268.
PMID: 34951974
Background: A rapid increase in circulating vaccine-derived poliovirus type 2 outbreaks, and the need to reserve inactivated poliovirus vaccine (IPV) for routine immunisation, has increased the value of fractional dose...